New Cholesterol Drugs Move Closer to EU Approval Medscape News Europe2 hours ago
Medscape,
European regulators have backed three new cholesterol-lowering therapies, potentially widening treatment options for patients…
New, Near-to-Market PCSK9s Could Help Patients Meet Cholesterol Targets
Pediatric News ,
The market for proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors to lower cholesterol is taking off with several…
Lerodalcibep Delivers Significant LDL-C Reduction for High-Risk Cardiovascular Patients
Pharmacy Times,
Lerodalcibep (LIB003; LIB Therapeutics) demonstrated significant reductions of low-density lipoprotein cholesterol (LDL-C) in…
Cholestérol : les nouveaux PCSK9 bientôt commercialisés devraient aider à atteindre les objectifs
Medscape,
L'introduction sur le marché américain – ou en passe de l’être – de plusieurs nouveaux médicaments inhibiteurs de la proprotéine…